Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K213342
    Date Cleared
    2022-01-05

    (90 days)

    Product Code
    Regulation Number
    888.3045
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    PRO-DENSE LoVisc Bone Graft Substitute

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    PRO-DENSE LoVisc™ resultant pastel is intended for use as a bone graft substitute to be injected or digitally packed into open bone voids/gaps that are not intrinsic to the stability of bony structure of the sketal system (i.e., the extremities, and pelvis) to cure in situ. These open bone voids may be the result of benign bone cysts and tumors (in adults and pediatric patients ≥ 6 years old), surgically created osseous defects created from traumatic injury to the bone. The paste provides a bone graft substitute that resorbs and is replaced with bone during the healing process.

    The PRO-DENSE LoVisc™ paste cured in situ provides an open void/gap filler that can augment provisional hardware (e.g. K Wires) to help support bone fragments during the surgical procedure. The cured paste acts only as a temporary support media and is not intended to provide structural support during the healing process.

    PRO-DENSE LoVisc™ is provided sterile for single use only.

    Device Description

    PRO-DENSE LoVisc™ Bone Graft Substitute is a calcium sulfate formulation consisting of a powder component and aqueous mixing solutions. When the two component types are mixed according to directions, an injectable paste is formed. This paste is subsequently injected and/or digitally packed into a bone void where the graft cures and hardens via hydration reactions.

    AI/ML Overview

    The provided text is a 510(k) summary for the PRO-DENSE LoVisc™ Bone Graft Substitute. It does not describe a study involving an AI device or present acceptance criteria and performance data for such a device. Instead, it focuses on demonstrating substantial equivalence of a medical device (bone graft substitute) to a predicate device based on non-clinical evidence.

    Therefore, I cannot extract the requested information regarding an AI device's acceptance criteria, study details, expert involvement, or ground truth establishment from this document.

    The document states:

    • "SUBSTANTIAL EQUIVALENCE - CLINICAL EVIDENCE: N/A"
    • "Ejection testing and LAL testing demonstrated that subject with increased working time, adjusted fill volumes, and updated kit accessories are equivalent to the predicate."

    This indicates that the equivalence was established through non-clinical testing, not a clinical study involving human readers or AI performance metrics.

    Ask a Question

    Ask a specific question about this device

    K Number
    K200507
    Date Cleared
    2020-10-21

    (233 days)

    Product Code
    Regulation Number
    888.3045
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    PRO-DENSE LoVisc Bone Graft Substitute

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    PRO-DENSE™ LoVisc Bone Graft Substitute is intended for use as a bone graft substitute to be injected or digitally packed into open bone voids/gaps that are not intrinsic to the stability of bony structure of the skeletal system (i.e., the extremities and pelvis) to cure in situ. These open bone voids may be the result of benign bone cysts and tumors (in adults and pediatric patients ≥ 6 years old), surgically created osseous defects created from traumatic injury to the bone. PRO-DENSE™ LoVisc Bone Graft Substitute resorbs and is replaced with bone during process.

    PRO-DENSE™ LoVisc Bone Graft Substitute cured in situ provides an open void/gap filler that can augment provisional hardware (e.g. K Wires) to help support bone fragments during the surgical procedure. The cured paste acts only as a temporary support media and is not intended to provide structural support during process.

    PRO-DENSE™ LoVisc Bone Graft Substitute is provided sterile for single use only.

    Device Description

    PRO-DENSE™ LoVisc Bone Graft Substitute is a composite of calcium sulfate and calcium phosphate. The formulation consists of a powder component and aqueous mixing solutions. When the two component types are mixed according to directions, an injectable paste is formed. This paste is subsequently injected and/or digitally packed into a bone void where the graft cures and hardens via hydration reactions.

    AI/ML Overview

    Based on the provided text, the document describes a 510(k) premarket notification for a medical device called PRO-DENSE™ LoVisc Bone Graft Substitute. This submission aims to demonstrate substantial equivalence to legally marketed predicate devices, primarily the PRO-DENSE Bone Graft Substitute (K181255/K182823).

    The information provided focuses on the non-clinical evidence used to support this claim of substantial equivalence. There is no mention of a study involving AI assistance, human readers, or image analysis. The device is a bone graft substitute, and its evaluation parameters are material properties and performance in a surgical context, not diagnostic accuracy based on algorithmic performance.

    Therefore, many of the requested sections related to acceptance criteria for an AI/imaging device, MRMC studies, standalone AI performance, and expert ground truth establishment for diagnostic purposes, are not applicable to the content of this document.

    Here's a breakdown of the requested information based only on the provided text, highlighting what is present and what is absent:


    Acceptance Criteria and Study for PRO-DENSE™ LoVisc Bone Graft Substitute

    The provided text describes a 510(k) submission for a bone graft substitute, not an AI or imaging device. The "acceptance criteria" discussed are related to the material and mechanical properties of the bone graft substitute, demonstrating its equivalence to existing predicate devices.

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria are implied to be within the range of the predicate device's characteristics. The performance is reported in terms of chemical and mechanical properties.

    Acceptance Criteria (Implied)Reported Device Performance
    Chemically equivalent to predicate"The characterization testing showed that the subject material is chemically equivalent to the predicate"
    Performs within the range of predicate"the bench top testing showed the graft performs within the range of the predicates."
    Specific physical/chemical properties consistent with predicateTested parameters listed below
    Injectability consistent with targeted improved flow"The additional liquid in the implant creates a bone graft material that can be more easily injected into bone voids."
    Set Time consistent with new formulation"The characteristics of the subject device are within the range of the predicate characteristics apart from set time and injectability."

    2. Sample Size Used for the Test Set and the Data Provenance

    These concepts are not applicable in the context of this device and submission type. The "test set" refers to the samples of the PRO-DENSE™ LoVisc Bone Graft Substitute tested for its material properties. There is no mention of sample sizes for individual tests. The "data provenance" would refer to where the bone graft material was manufactured and tested, which is not specified beyond "Wright Medical Technology, Inc." in Memphis, TN. Data is from benchtop testing, not human subjects.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This information is not applicable. The "ground truth" for a bone graft substitute is its inherent material properties and performance characteristics, measured through standardized assays (e.g., FTIR, XRD, mechanical testing). Experts would be involved in the design and interpretation of these bench tests, but not in establishing a "ground truth" in the diagnostic sense.

    4. Adjudication Method for the Test Set

    This is not applicable. Adjudication methods (like 2+1, 3+1) are used for resolving disagreements among multiple human readers in diagnostic studies. For material property testing, results are typically quantitative and objective measurements.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done

    No, an MRMC comparative effectiveness study was not done. The document explicitly states "(b)(2) SUBSTANTIAL EQUIVALENCE - CLINICAL EVIDENCE N/A", meaning no human clinical studies were performed or are being presented for this submission. Therefore, no information on human reader improvement with AI assistance is available.

    6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done

    No, a standalone algorithm performance study was not done. This device is a physical bone graft substitute, not a software algorithm.

    7. The Type of Ground Truth Used

    The "ground truth" for this device's performance is established through objective, standardized benchtop testing of chemical and mechanical properties. This includes:

    • Fourier Transform Infrared Spectroscopy (FTIR)
    • X-ray Diffraction Analysis (XRD)
    • Dissolution
    • Porosity
    • Density
    • Maximum Exothermic Temperature
    • Dilute Slurry pH
    • Vicat and Gilmore Set Time
    • Injectability
    • DTS (unspecified, likely a material property test)
    • Hardware interaction
    • Sterilization
    • Biocompatibility
    • Pyrogenicity
    • LAL testing

    8. The Sample Size for the Training Set

    This concept is not applicable. There is no "training set" as this is not an AI/machine learning device.

    9. How the Ground Truth for the Training Set Was Established

    This concept is not applicable.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1